These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17420214)

  • 1. Inhibitory activities of three classes of acyclic nucleoside phosphonates against murine polyomavirus and primate simian virus 40 strains.
    Lebeau I; Andrei G; Krecmerová M; De Clercq E; Holy A; Snoeck R
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2268-73. PubMed ID: 17420214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activities of several classes of acyclic nucleoside phosphonates against camelpox virus replication in different cell culture models.
    Duraffour S; Snoeck R; Krecmerová M; van Den Oord J; De Vos R; Holy A; Crance JM; Garin D; De Clercq E; Andrei G
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4410-9. PubMed ID: 17893157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-[2-phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines: a new class of acyclic pyrimidine nucleoside phosphonates with antiviral activity.
    Balzarini J; Pannecouque C; Naesens L; Andrei G; Snoeck R; De Clercq E; Hocková D; Holý A
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1321-7. PubMed ID: 15571252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of herpesvirus replication by hexadecyloxypropyl esters of purine- and pyrimidine-based phosphonomethoxyethyl nucleoside phosphonates.
    Prichard MN; Hartline CB; Harden EA; Daily SL; Beadle JR; Valiaeva N; Kern ER; Hostetler KY
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4326-30. PubMed ID: 18852272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines.
    De Clercq E; Andrei G; Balzarini J; Leyssen P; Naesens L; Neyts J; Pannecouque C; Snoeck R; Ying C; Hocková D; Holý A
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):331-41. PubMed ID: 16247948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activities of various compounds against murine and primate polyomaviruses.
    Andrei G; Snoeck R; Vandeputte M; De Clercq E
    Antimicrob Agents Chemother; 1997 Mar; 41(3):587-93. PubMed ID: 9055998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N(4)-Acyl derivatives as lipophilic prodrugs of cidofovir and its 5-azacytosine analogue, (S)-HPMP-5-azaC: chemistry and antiviral activity.
    Krečmerová M; Pohl R; Masojídková M; Balzarini J; Snoeck R; Andrei G
    Bioorg Med Chem; 2014 May; 22(10):2896-906. PubMed ID: 24731540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acyclic nucleoside phosphonates with 5-azacytosine base moiety substituted in C-6 position.
    Krecmerová M; Masojídková M; Holý A
    Bioorg Med Chem; 2010 Jan; 18(1):387-95. PubMed ID: 19914075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New prodrugs of two pyrimidine acyclic nucleoside phosphonates: Synthesis and antiviral activity.
    Krečmerová M; Dračínský M; Snoeck R; Balzarini J; Pomeisl K; Andrei G
    Bioorg Med Chem; 2017 Sep; 25(17):4637-4648. PubMed ID: 28757102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]-pyrimidine against multidrug-resistant hepatitis B virus mutants.
    Brunelle MN; Lucifora J; Neyts J; Villet S; Holy A; Trepo C; Zoulim F
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2240-3. PubMed ID: 17371827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activities of different classes of acyclic nucleoside phosphonates against BK virus in primary human renal cells.
    Topalis D; Lebeau I; Krecmerová M; Andrei G; Snoeck R
    Antimicrob Agents Chemother; 2011 May; 55(5):1961-7. PubMed ID: 21343444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antiviral activities of hexadecyloxypropyl prodrugs of acyclic nucleoside phosphonates containing guanine or hypoxanthine and a (S)-HPMP or PEE acyclic moiety.
    Tichý T; Andrei G; Snoeck R; Balzarini J; Dračínský M; Krečmerová M
    Eur J Med Chem; 2012 Sep; 55():307-14. PubMed ID: 22858222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activities of acyclic nucleoside phosphonates against Orf virus in human and ovine cell monolayers and organotypic ovine raft cultures.
    Dal Pozzo F; Andrei G; Holy A; Van Den Oord J; Scagliarini A; De Clercq E; Snoeck R
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4843-52. PubMed ID: 16304144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: activity against adenovirus replication in vitro.
    Hartline CB; Gustin KM; Wan WB; Ciesla SL; Beadle JR; Hostetler KY; Kern ER
    J Infect Dis; 2005 Feb; 191(3):396-9. PubMed ID: 15633099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions.
    Andrei G; Fiten P; Froeyen M; De Clercq E; Opdenakker G; Snoeck R
    Antivir Ther; 2007; 12(5):719-32. PubMed ID: 17713155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The acyclic nucleoside phosphonates (ANPs): Antonín Holý's legacy.
    De Clercq E
    Med Res Rev; 2013 Nov; 33(6):1278-303. PubMed ID: 23568857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xanthine-based acyclic nucleoside phosphonates with potent antiviral activity against varicella-zoster virus and human cytomegalovirus.
    Baszczyňski O; Kaiser MM; Česnek M; Břehová P; Jansa P; Procházková E; Dračínský M; Snoeck R; Andrei G; Janeba Z
    Antivir Chem Chemother; 2018; 26():2040206618813050. PubMed ID: 30497281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antiviral activity and mechanism of action of (S)-[3-hydroxy-2-(phosphonomethoxy)propyl] (HPMP) nucleosides.
    Magee WC; Evans DH
    Antiviral Res; 2012 Nov; 96(2):169-80. PubMed ID: 22960154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the mechanism of action of cidofovir and other acyclic nucleoside phosphonates against polyoma- and papillomaviruses and non-viral induced neoplasia.
    Andrei G; Topalis D; De Schutter T; Snoeck R
    Antiviral Res; 2015 Feb; 114():21-46. PubMed ID: 25446403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of the anti-orf virus activity of alkoxyalkyl esters of CDV, cCDV and (S)-HPMPA.
    Dal Pozzo F; Andrei G; Lebeau I; Beadle JR; Hostetler KY; De Clercq E; Snoeck R
    Antiviral Res; 2007 Jul; 75(1):52-7. PubMed ID: 17184854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.